Preventive Maintenance Service of a 700 MHz NMR Instrument
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Cancer Institute (NCI), on behalf of the Laboratory of Biochemistry and Molecular Biology, intends to award a non-competitive, firm-fixed-price purchase order for Preventive Maintenance Services for a 700 MHz NMR Instrument. This acquisition is specifically for Bruker Biospin Corporation, identified as the sole authorized provider of manufacturer-specific service and OEM parts. The NMR instrument is critical for NCI's cancer-related research on chromatin and protein structures. Quotations are due March 21, 2026.
Scope of Work
This requirement covers comprehensive preventive maintenance for a government-owned 700 MHz Nuclear Magnetic Resonance Spectrometer Console (System ID BH006410). Services include:
- Two (2) preventive maintenance inspections (PMI) per contract period, performed on-site by technically qualified, factory-trained personnel.
- Thorough cleaning, calibration, adjustment, inspection, lubrication, and testing during PMIs.
- Emergency service within twenty-four (24) hours for malfunctions during normal working hours.
- Provision of all labor, materials, and equipment.
- Furnishing of all required replacement parts (new or re-manufactured to original specifications), excluding consumables.
- Coverage for the NMR console, magnet, cryoplatform, cooling unit, and cryoprobe.
Contract & Timeline
- Contract Type: Firm Fixed-Price Purchase Order.
- Period of Performance: May 22, 2026, through May 21, 2031 (a base year plus four 12-month option periods).
- Place of Performance: National Cancer Institute, 37 Convent Dr., Bldg 37, Room B134, Bethesda, MD 20814.
- Set-Aside: Not set-aside; this is a non-competitive acquisition.
- NAICS: 811210 (Electronic and Precision Equipment Repair and Maintenance) with a $34M small business size standard.
- Quotation Due: March 21, 2026, by 4:00 p.m. EST.
- Published: May 18, 2026.
Submission & Evaluation
Quotations must be submitted electronically to Katy.Werby@hhs.gov and reference Solicitation Number 75N98026Q00047-RFQ. Submissions must include:
- Unit price, list price, shipping/handling costs, delivery days, delivery terms, prompt payment discount, F.O.B. Point, product/catalog number(s), and product description.
- Unique Entity ID (UEI), Taxpayer Identification Number (TIN), and certification of business size.
- Active registration in SAM.gov is required.
Evaluation will focus on:
- Conformance to solicitation requirements.
- Provision of manufacturer-authorized service, including OEM parts, software updates, and technical support.
- Fair and reasonable pricing.
- Past performance and other relevant information may be considered.
Additional Notes
This is a combined synopsis/solicitation for commercial services. The government's determination to proceed non-competitively is based on Bruker Biospin Corporation being the sole authorized provider. However, information received from other interested parties will be considered to determine if a competitive procurement is feasible.